PMID: 9003851Jan 1, 1997Paper

Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis

The Journal of Pediatrics
G LepageA Rasquin-Weber

Abstract

Several clinical trials of ursodeoxycholic acid (UDCA) have shown improvement of liver-function test results in cystic fibrosis (CF) with liver disease; however, there is no evidence that the long-term course will be affected. In view of the observations that UDCA can change the lipid profile and that patients with CF and liver disease are more likely to have essential fatty acid (EFA) deficiency, we elected to examine changes in the lipid profile and in the status of fat-soluble vitamins in response to UDCA. Nineteen children with CF and liver dysfunction were recruited for a double-blind, crossover study of 1 year's duration, followed by treatment of the entire group. UDCA was administered at a dosage of 15 mg/kg per day, which, in the absence of a 50% decrease of alanine transaminase or aspartate transaminase or both within 2 months, was increased to 30 mg/kg per day. At entry, all patients had biochemical evidence of EFA deficiency. The lipid profiles during an average period of 25 months of follow-up showed a significant decrease in triglycerides (p <0.002), cholesterol (p <0.02), and total fatty acids (p <0.006). In addition, UDCA therapy led to an improvement in EFA status, as indicated by an increase (p <0.05) in the n-...Continue Reading

References

Jan 1, 1978·Acta paediatrica Scandinavica·R KraemerE Rossi
Apr 8, 1976·The New England Journal of Medicine·F R Smith, D S Goodman
Oct 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C ColomboK D Setchell
Jan 1, 1992·Annual Review of Nutrition·R BlomhoffK R Norum
Dec 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A CrosignaniK D Setchell
Jan 1, 1990·Journal of Pediatric Gastroenterology and Nutrition·J SarlesF Giraud
Sep 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R HultcrantzB Strandvik
Mar 1, 1985·Prostaglandins, Leukotrienes, and Medicine·D J SegarnickJ Rotrosen
Jan 1, 1986·Pediatric Research·E H MischlerR J Lemen
May 1, 1986·Journal of Pediatric Gastroenterology and Nutrition·M RasmussenK R Norum
May 1, 1986·Journal of Pediatric Gastroenterology and Nutrition·R A GibsonG P Davidson
Jan 1, 1982·Journal of Pediatric Gastroenterology and Nutrition·C C RoyR Lasalle
Jan 1, 1994·Scandinavian Journal of Gastroenterology. Supplement·E RodaG Mazzella
Jan 1, 1994·Scandinavian Journal of Gastroenterology. Supplement·B Angelin, S Eusufzai
May 12, 1994·The New England Journal of Medicine·R E PouponB Balkau
May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E J HeathcoteL J Scully
Feb 1, 1994·Nutrition Reviews·R Blomhoff
May 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R J SokolK O'Brien
Apr 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R E PouponR Poupon

❮ Previous
Next ❯

Citations

Dec 2, 1999·Journal of Hepatology·C ColomboP M Battezzati
Apr 13, 1999·Gastroenterology Clinics of North America·A StiehlP Sauer
Apr 5, 2003·Best Practice & Research. Clinical Gastroenterology·Reuben Jackson, Paul B Pencharz
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·M SinaasappelG Döring
Sep 22, 2012·The Journal of Clinical Investigation·Alicia K OlivierJohn F Engelhardt
Oct 22, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Stephanie Van BiervlietArmand Christophe
Jan 22, 2004·Chest·James R YankaskasDavid Rodman
Dec 8, 2004·Journal of Hepatology·Thierry LamireauFernando Alvarez
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Ristan M GreerScott C Bell
Nov 21, 2000·Pediatric Dermatology·G L DarmstadtV A Ziboh
Aug 30, 2017·The Cochrane Database of Systematic Reviews·Senthil K PalaniappanIndra van Mourik
Sep 29, 2007·Current Opinion in Pulmonary Medicine·Carla Colombo
Feb 26, 1999·Pediatric Annals·S H Erdman
Jan 30, 2008·Annals of Nutrition & Metabolism·Stephanie Van BiervlietArmand Christophe
Feb 2, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Francesco RaimondiRoberto Paludetto
Sep 12, 2017·The Cochrane Database of Systematic Reviews·Katharine ChengRosalind L Smyth
Apr 22, 2009·Current Opinion in Gastroenterology·Katie Moyer, William Balistreri
Sep 20, 1997·The Annals of Pharmacotherapy·H ScherP B McCray
Apr 1, 2020·The Cochrane Database of Systematic Reviews·Senthil K PalaniappanIndra van Mourik
May 31, 2002·The American Journal of Clinical Nutrition·Veronica FigueroaAntoinette Moran
Nov 15, 2008·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Crésio de Aragão Dantas Alves, Daniela Seabra Lima
Nov 19, 2020·International Journal of Molecular Sciences·Katharina Staufer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.